Liposome Lipid-Based Formulation Has the Least Influence on rAAV Transduction Compared to Other Transfection Agents

Recombinant adeno-associated virus (rAAV) vectors are considered ideal vehicles for human gene therapy. Meanwhile, non-viral strategies, such as transfection agents (TAs), have also shown promise to deliver genetic materials, such as siRNA. Transduction with the rAAV vector is performed concurrently...

Descripción completa

Detalles Bibliográficos
Autores principales: Guo, Pengpeng, Yu, Chenghui, Wang, Qingxin, Zhang, Ruirong, Meng, Xianze, Feng, Yinglu
Formato: Online Artículo Texto
Lenguaje:English
Publicado: American Society of Gene & Cell Therapy 2018
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6054704/
https://www.ncbi.nlm.nih.gov/pubmed/30038940
http://dx.doi.org/10.1016/j.omtm.2018.04.004

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6054704/
https://www.ncbi.nlm.nih.gov/pubmed/30038940
http://dx.doi.org/10.1016/j.omtm.2018.04.004

Ejemplares similares